HOME > About Walvax > Product

Group A and C Meningococcal Polysaccharide Vaccine

 

Market Approval time
The product was on market officially in March 23, 2012

DESCRIPTION

Group A and C Meningococcal Polysaccharide Vaccine is a preparation of purified capsular polysaccharide antigens extracted from the cultures of Neisseria meningitides group A and C, respectively, with lactose as stabilizer for finial lyophilization. This vaccine is a vaccine in the form of powder and diluent for suspensionfor injection (1 dose of 0.5 mL).
One dose of 0.5ml contains:
Group A Meningococcal Polysaccharide………………………………………..…50μg
Group C Meningococcal Polysaccharide……………………………………..……50μg
Excipients: Lactose andsodium chloride
Diluent: Sterile water for injection

 

INDICATIONS
The vaccine is used to preventdiseases caused by the bacterium Neisseria Meningitidis group A orC in adults and in children from the age of two years, such as cerebrospinal meningitis and septicemia.
This vaccine does not protect against other groups of meningococci or other organismsresponsible for meningitis or septicaemia (generalized infection).
 

 
ADMINISTRATION AND DOSAGE
Reconstitute the vaccine with the accompanying diluent according to indicated amount. With gentle shaking the dried cake is easily dissolved. After reconstitution the vaccine should be used immediately.The vaccine shall be injected subcutaneously into lateral upper arm.A single dose of 0.5ml should be administered only once for each human. Immunization shall be completed before the epidemic season of cerebrospinal meningitis. 
 
SHELF LIFE 
The shelf life is 24 months. The expiry date of the vaccine is indicated on the label and packaging.